BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA‐like breast cancers treated with neoadjuvant chemotherapy
Mamoru Takada; Shigenori Nagai; Masayuki Haruta; Ryuichi P. Sugino; Katsunori Tozuka; Hiroyuki Takei; Fumie Ohkubo; Kenichi Inoue; Masafumi Kurosumi; Masaru Miyazaki; Aiko Sato‐Otsubo; Yusuke Sato; Seishi Ogawa; Yasuhiko Kaneko
Author Information: Research Institute for Clinical Oncology, Saitama Cancer Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.